GAK and kidney failure: To determine whether mitigating calpain activation in Gak-KO mice would inhibit disease progression, we administered a calpain inhibitor that inhibits calpain-1/-2 activities and observed reduced albuminuria, kidney failure, and death in the Gak-KO mice.